Frontlight ResearchEarly access
Trial site
Herzzentrum Dresden GmbH Universitaetsklinik
- 13running trials
- 7closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Heart failure11 trials
- Coronary artery disease3 trials
- Atrial fibrillation2 trials
- Familial hypercholesterolaemia2 trials
- High blood pressure2 trials
- Amyloidosis1 trial
- Chronic kidney disease1 trial
- Myocarditis1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 26 trials
- Phase 43 trials
- Status
- Recruiting8 trials
- Completed7 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Novo Nordisk A/S6 trials
- Novartis Pharma AG2 trials
- Alnylam Pharmaceuticals1 trial
- AstraZeneca1 trial
- Boehringer Ingelheim1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Colchicine After Electrocardioversion for Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure5 recruiting
- High blood pressure2 recruiting
- Amyloidosis1 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Myocarditis1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026